FI960077A0 - Uudet (1-fenyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina - Google Patents
Uudet (1-fenyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineinaInfo
- Publication number
- FI960077A0 FI960077A0 FI960077A FI960077A FI960077A0 FI 960077 A0 FI960077 A0 FI 960077A0 FI 960077 A FI960077 A FI 960077A FI 960077 A FI960077 A FI 960077A FI 960077 A0 FI960077 A0 FI 960077A0
- Authority
- FI
- Finland
- Prior art keywords
- heterocyclyl
- phenyl
- new
- nervous system
- protective agents
- Prior art date
Links
- 150000001335 aliphatic alkanes Chemical class 0.000 title 1
- 210000000653 nervous system Anatomy 0.000 title 1
- 239000003223 protective agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE19939302333A SE9302333D0 (sv) | 1993-07-06 | 1993-07-06 | New compounds |
| PCT/SE1994/000664 WO1995001967A1 (en) | 1993-07-06 | 1994-07-05 | Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI960077A7 FI960077A7 (fi) | 1996-01-08 |
| FI960077A0 true FI960077A0 (fi) | 1996-01-08 |
Family
ID=20390540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI960077A FI960077A0 (fi) | 1993-07-06 | 1996-01-08 | Uudet (1-fenyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5747515A (no) |
| EP (1) | EP0707573A1 (no) |
| JP (1) | JPH08512313A (no) |
| CN (1) | CN1044705C (no) |
| AU (1) | AU691191B2 (no) |
| BR (1) | BR9406924A (no) |
| CA (1) | CA2164876A1 (no) |
| CZ (1) | CZ4196A3 (no) |
| FI (1) | FI960077A0 (no) |
| HU (1) | HUT74673A (no) |
| IS (1) | IS1742B (no) |
| NO (1) | NO305862B1 (no) |
| NZ (1) | NZ268690A (no) |
| PL (1) | PL179021B1 (no) |
| RU (1) | RU2137763C1 (no) |
| SE (1) | SE9302333D0 (no) |
| SK (1) | SK281025B6 (no) |
| WO (1) | WO1995001967A1 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726569D0 (en) * | 1997-12-16 | 1998-02-11 | Univ Southampton | Neuroprotective agents |
| FR2774596B1 (fr) * | 1998-02-11 | 2000-03-17 | Rhone Poulenc Rorer Sa | Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer |
| EP1073640B1 (en) | 1998-04-23 | 2005-04-13 | Takeda Pharmaceutical Company Limited | Naphthalene derivatives, their production and use |
| US6503935B1 (en) | 1998-08-07 | 2003-01-07 | Abbott Laboratories | Imidazoles and related compounds as α1A agonists |
| US6156775A (en) * | 1999-03-01 | 2000-12-05 | Novartis Ag | Use of fluorinated triazoles in treating affective and attention disorders |
| WO2000078727A1 (en) | 1999-06-22 | 2000-12-28 | Takeda Chemical Industries, Ltd. | Process for the preparation of imidazole derivatives |
| SE9904177D0 (sv) * | 1999-11-18 | 1999-11-18 | Astra Ab | Novel compounds |
| RU2275195C2 (ru) * | 2003-06-19 | 2006-04-27 | Наталья Борисовна Кармен | Средство для защиты головного мозга от гипоксически-ишемического повреждения |
| KR20060133084A (ko) * | 2004-04-03 | 2006-12-22 | 아스트라제네카 아베 | 치료제 |
| WO2008064317A1 (en) * | 2006-11-22 | 2008-05-29 | University Of Medicine And Dentistry Of New Jersey | Lipophilic opioid receptor active compounds |
| EP2751117A4 (en) * | 2011-08-30 | 2015-06-24 | Innocrin Pharmaceuticals Inc | METALLOENZYMHEMMERVERBINDUNGEN |
| CN104932538B (zh) * | 2015-07-03 | 2018-02-23 | 中国计量科学研究院 | 光机旋转装置 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE121520C (no) * | ||||
| GB2101114B (en) * | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
| US4649146A (en) * | 1983-01-31 | 1987-03-10 | Fujisawa Pharmaceutical Co., Ltd. | Thiazole derivatives and pharmaceutical composition comprising the same |
| FR2625199B1 (fr) * | 1987-12-23 | 1991-03-22 | Irceba | Derives oxyimino du thiazole, procede de preparation et utilisation en therapeutique |
| DE3884966T2 (de) * | 1987-12-29 | 1994-02-03 | Dainippon Pharmaceutical Co | Mittel zur behandlung der ischämischen gehirnkrankheit. |
| JPH01249760A (ja) * | 1988-03-29 | 1989-10-05 | Yamaha Corp | ホトクロミック化合物 |
| JPH0291076A (ja) * | 1988-09-28 | 1990-03-30 | Tokuyama Soda Co Ltd | フォトクロミック性化合物及びその製造方法 |
| GB8909737D0 (en) * | 1989-04-27 | 1989-06-14 | Shell Int Research | Thiazole derivatives |
| TW224461B (no) * | 1990-09-18 | 1994-06-01 | Ciba Geigy Ag | |
| US5356898A (en) * | 1991-01-31 | 1994-10-18 | Warner-Lambert Company | Substituted 4,6-di-tertiary-butyl 5-hydroxy-pyrimidines |
| US5177079A (en) * | 1991-01-31 | 1993-01-05 | Warner-Lambert Company | 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| GB9125924D0 (en) * | 1991-06-18 | 1992-02-05 | Orion Yhtymae Oy | Stereoisomers of an imidazole derivative |
-
1993
- 1993-07-06 SE SE19939302333A patent/SE9302333D0/xx unknown
-
1994
- 1994-06-23 IS IS4183A patent/IS1742B/is unknown
- 1994-07-05 AU AU71978/94A patent/AU691191B2/en not_active Ceased
- 1994-07-05 SK SK1599-95A patent/SK281025B6/sk unknown
- 1994-07-05 US US08/379,467 patent/US5747515A/en not_active Expired - Fee Related
- 1994-07-05 WO PCT/SE1994/000664 patent/WO1995001967A1/en not_active Ceased
- 1994-07-05 EP EP94921148A patent/EP0707573A1/en not_active Withdrawn
- 1994-07-05 NZ NZ268690A patent/NZ268690A/en unknown
- 1994-07-05 HU HU9503742A patent/HUT74673A/hu unknown
- 1994-07-05 PL PL94312427A patent/PL179021B1/pl unknown
- 1994-07-05 CZ CZ9641A patent/CZ4196A3/cs unknown
- 1994-07-05 CA CA002164876A patent/CA2164876A1/en not_active Abandoned
- 1994-07-05 CN CN94192705A patent/CN1044705C/zh not_active Expired - Fee Related
- 1994-07-05 BR BR9406924A patent/BR9406924A/pt not_active Application Discontinuation
- 1994-07-05 JP JP7503999A patent/JPH08512313A/ja active Pending
- 1994-07-05 RU RU96102574A patent/RU2137763C1/ru active
-
1996
- 1996-01-04 NO NO960029A patent/NO305862B1/no not_active IP Right Cessation
- 1996-01-08 FI FI960077A patent/FI960077A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO305862B1 (no) | 1999-08-09 |
| NZ268690A (en) | 1997-11-24 |
| AU691191B2 (en) | 1998-05-14 |
| FI960077A7 (fi) | 1996-01-08 |
| CN1126990A (zh) | 1996-07-17 |
| NO960029L (no) | 1996-01-04 |
| PL312427A1 (en) | 1996-04-29 |
| SK281025B6 (sk) | 2000-11-07 |
| SK159995A3 (en) | 1996-06-05 |
| WO1995001967A1 (en) | 1995-01-19 |
| RU2137763C1 (ru) | 1999-09-20 |
| US5747515A (en) | 1998-05-05 |
| CA2164876A1 (en) | 1995-01-19 |
| HUT74673A (en) | 1997-01-28 |
| EP0707573A1 (en) | 1996-04-24 |
| IS1742B (is) | 2000-02-21 |
| CZ4196A3 (en) | 1996-06-12 |
| CN1044705C (zh) | 1999-08-18 |
| IS4183A (is) | 1995-01-07 |
| HU9503742D0 (en) | 1996-02-28 |
| BR9406924A (pt) | 1996-07-30 |
| AU7197894A (en) | 1995-02-06 |
| PL179021B1 (pl) | 2000-07-31 |
| JPH08512313A (ja) | 1996-12-24 |
| NO960029D0 (no) | 1996-01-04 |
| SE9302333D0 (sv) | 1993-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI932891L (fi) | Nya pyrazolderivat, foerfarande foer deras framstaellning och farmaceutiska preparat innehaollande desamma | |
| FI934220A0 (fi) | Piperidinderivat, framstaellning daerav och anvaendning daerav vid en terapi | |
| FI930601L (fi) | 3,5-substituerade bensoylguanidiner, foerfarande foer framstaellning daerav, deras anvaendning laekemedel eller diagnostiskt aemne och laekemedel, som innehaoller dessa | |
| DE69324506D1 (de) | Gekühlte turbinenschaufel | |
| FI970310A0 (fi) | 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina | |
| FI933253L (fi) | Nya amylinantagonistpeptider och anvaendning som amylinantagonister | |
| FI960076A0 (fi) | Uudet (1-heteroatsolyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina | |
| FI960077A0 (fi) | Uudet (1-fenyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina | |
| FI932351A7 (fi) | Cyklopeptider och deras anvaendning som resorptionsbefraemjande medel vid applikation pao slemhinnor | |
| FI964936A0 (fi) | Bentsopyraaneja ja niiden käyttö terapeuttisina aineina | |
| FI925570L (fi) | Nya i vatten oloesliga katjoniska kopolymerer, nya dispersioner och anvaendning av dessa vid bestrykning av papper | |
| FI923050L (fi) | Nya benzomorfaner och deras anvaendning som laekemedel | |
| FI924934L (fi) | Nya ftalaziner som innehaoller en eter- eller tioetergruppering i 1-staellning och foerfarande foer deras framstaellning | |
| FI960367A0 (fi) | Uusia dialkoksipyridinyylibentsimidatsolijohdannaisia | |
| DK0660715T3 (da) | Carbostyrilderivater som antiarytmiske midler | |
| FI930495A7 (fi) | Nya herbicider | |
| FI956150A7 (fi) | Isokinoliinijohdannaisia terapeuttisina aineina | |
| FI964879A0 (fi) | Uusia, 1,1-bis(heteroazolyyli)alkaanijohdoksia ja niiden käyttö hermostoa suojelevina aineina | |
| FI935509L (fi) | Sampolymerer baserade pao cykliska estrar och deras anvaendning som kirurgiska implantat | |
| FI962019A0 (fi) | Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
| FI933403L (fi) | Nya cykloalkylalkylaminer, som aer sigmareceptorligander, foerfarande foer framstaellning av dessa och anvaendning av dessa vid terapi | |
| FI942933A0 (fi) | Uusia 3-halogeeni-5-halogeenimetyyli-2-oksatsolidinoneja ja niiden käyttö mikrobisideina | |
| FI942646A0 (fi) | Uudet tiosemikarbatsonitionit | |
| FI941300A7 (fi) | Bentseenijohdannaiset | |
| FI934252L (fi) | 1,5,6,7-tetrahydro-4H-indazol-4-oner innehaollande laekemedel, nya 1,5,6,7-tetrahydro-4H-indazol-4-oner och foerfarande foer deras framstaellning |